Governments throughout the world have struggled for decades to ensure
the availability of narcotic analgesics for legitimate medical and sci
entific purposes while controlling the abuse and illegal diversion of
such substances. While the international drug-control system has effec
tively limited illicit trafficking of opioids, concerns remain about i
ts effectiveness in ensuring the availability of these drugs for legit
imate purposes. In the United States, federal legislation accommodates
the we of controlled substances for medical and scientific purposes m
ore effectively than does state law. Many states' controlled substance
laws hinder appropriate opioid prescribing through (a) the use of ill
-defined terms, (b) restriction of pain prescriptions to a specific nu
mber of dosage units; and/or (c) utilization of multiple-copy prescrip
tion programs. A more efficient state approach to monitoring inappropr
iate schedule II prescribing and dispensing may be through an electron
ic, computer-based pharmacy point-of-sale system, through which pharma
cists can be acted instantaneosly to patients receiving the same drug
from multiple pharmacies. In addition, states should consider modifyin
g their approaches to drug abuse by adopting the revised Uniform Contr
olled Substances Act and/or establishing state pain initiatives.